Arbutus Biopharma(ABUS) - 2023 Q2 - Earnings Call Presentation

Corporate Presentation NASDAQ: ABUS www.arbutusbio.com August 3, 2023 © 2023 Arbutus Biopharma, Inc. Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Canadian securities laws. All statements that are not historical facts are hereby identified as forward-looking statements for this purpose and include, among others, statements relating to: the potential market opportunity for HBV; Arbutus’ abil ...